Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2021-11-03, Stock:LLY, The news for the past five days is as follows:
2021-10-27: NEWS1: 10 Stocks Making Noise After Releasing Their Earnings Reports.NEWS2: Healthcare ETFs in Focus as Q3 Earnings Unfold.NEWS3: Stock Market News for Oct 27, 2021.NEWS4: Eli Lilly Pitches Alzheimer Drug to the FDA, Aiming to Leapfrog Biogen.
2021-10-28: NEWS1: Additional Verzenio® (abemaciclib) Phase 3 monarchE Trial Data Published in the Annals of Oncology.NEWS2: Down 76%: Is Cortexyme Stock a Bargain?.NEWS3: Inventiva Plans To Start Lanifibranor Combo Study In NASH, Diabetes In 2022.NEWS4: Cortexyme's Alzheimer's Drug Fails -- 2 Lessons for Investors.
2021-10-29: NEWS1: CEO details plan for gene therapy firm's $125M RTP expansion.NEWS2: Top Research Reports for Alphabet, Eli Lilly & Sony.NEWS3: Pharma Stock Roundup: Big Pharma Q3 Results, FDA Panel's Vote for PFE COVID Jab.NEWS4: Why Eli Lilly and Company (NYSE:LLY) may be Cheap and has Growth Driven by Capital Investments.
2021-11-01: NEWS1: Lilly to Participate in Bernstein's Second Annual Operational Decisions Conference.NEWS2: The Zacks Analyst Blog Highlights: Alphabet, Eli Lilly, Sony, American Express and Southern Company.NEWS3: What Is the Nifty 50?.
2021-11-02: NEWS1: Why Eli Lilly Shares Traded Higher Today.NEWS2: Metacrine Posts Data From MET409 Combination Trial In Diabetes, NASH Patients.NEWS3: UPDATE 2-Lilly pulls COVID-19 treatment from EU review while U.S. stocks up.NEWS4: Was The Smart Money Right About Eli Lilly and Company (LLY)?.NEWS5: The Daily Biotech Pulse: Pfizer Reports Solid Q3 Earnings, Regulatory Setback For Legend, Lilly to Supply Additional COVID-19 Antibody Cocktails To US.NEWS6: UPDATE 1-U.S. buys more doses of Lilly's COVID-19 treatment for $1.29 bln.NEWS7: Lilly to supply 614,000 additional doses of bamlanivimab and etesevimab to the U.S. Government for the treatment or post-exposure prevention of COVID-19.

Answer: Rise